Concomitant midcyclic GnRH antagonist treatment (Ganirelix) at different dosages;Kontrollierte ovarielle hyperstimulation mit rekombinantem FSH und begleitender mittzyklischer GnRH-antagonistenmedikation (Ganirelix) in verschiedenen dosierungen

Geburtshilfe und Frauenheilkunde

Volumn 59, Issue 5, 1999, Pages 209-214

  Weiss, J M ^a   Felberbaum, R ^b   Montzka, P ^b   Ludwig, M ^b   Strik, D ^b   Bals Pratsch, M ^b   Al Hasani, S ^b   Ortmann, O ^b   Diedrich, C ^b   Diedrich, K ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ARTICLE; CHRONOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EMBRYO; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; OOCYTE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033044310     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-14190     Document Type: Article

References (21)

1. Matsou, H., Y. Baba, R. M. G. Nair, A. V. Schally: Structure of porcrine LH and FSH releasing factor. The proposed amino acid sequence. Biochem. Biophys. Res. Commun. 43 (1971) 1334-1339
2. Knobil, E.: The neuroendocrine control of the menstrual cycle. Recent Prog. Horm. Res. 36 (1981) 53-88
3. Clayton, R. N.: Gonadotropin-releasing hormone: Its actions and receptors. J. Endocrinol. 120 (1991) 11-19
4. Kiesel, L., B. Runnebaum: Gonadotropin-releasing-Hormon und Analoga - Physiologie und Pharmakologie. Gynäkol. Geburth. 32 (1992) 22-30
5. Diedrich, K., C. Diedrich, E. Santos, C. Zoll, S. Al-Hasani, T. Reissmann, D. Krebs, D. Klingmüller: Suppression of the endogenous luteinizing hormone surge ba the gonadotropin releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum. Reprod. 9 (1994) 788-791
6. Stanger, J. D., J. L. Yovich: Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during follicular phase. Brit. J. Obstet. Gynecol. 92 (1985) 385-393
7. Loumaye, E.: The control of endogenous secretion of LH by Gonadotropin-releasing-hormone agonists during ovarian hyperstimulation for in vitro fertilization and embryo transfer. Hum. Reprod. 5 (1990) 357-376
8. Tarlatzis, B. C., G. Pados, J. Bontis, S. Lagos, C. Grimbizis, E. Spanos, S. Mantalenakis: Ovarian stimulation with buserelin/ HMG/HCG: prospective randomized study of short versus long protocol. Hum. Reprod. 8 (1993) 807-812
9. Rabinovici, J., P. Rothman, S. E. Monroe, C. Nerenberg, R. B. Jaffe: Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: Studies in postmenopausal women. J. Clin. Endocrinol. Metab. 11; 75 (5) (1992) 1220-1225
10. Nestor, J. J. Jr., R. Tahilramani, T. L. Ho, J. C. Goodpasture, B. H. Vickery, P. Ferrandon: Potent gonadotropin releasing hormone antagonists with low histamine-releasing activity. J. Med. Chem. 16; 35 (21) (1992) 3942-3948
11. Nelson, L. R., V. Y. Fujimoto, R. B. Jaffe, S. E. Monroe: Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix). Fertil. Steril. 63 (5) (1995) 963-969
12. Felberbaum, R., T. Reissmann, W. Küpker, S. Al-Hasani, O. Bauer, T. Schill, C. Zoll, C. Diedrich, K. Diedrich: Hormone profiles under ovarian stimulation with human menopausal Gonadotropin (HMG) and concomitant administration of the Gonadotropin releasing hormone (GnRH)-Antagonist Cetrorelix at different dosages. J. Assist. Reprod. Genetics 13 (3) (1996) 216-222
13. Felberbaum, R. E., T. Reissmann, W. Küpker, O. Bauer, S. Al-Hasani, C. Diedrich, K. Diedrich: Preserved pituitary reponse under ovarian stimulation with HMG and GnRH-antagonists (Cetrorelix) in woman with tubal infertility. Europ. J. Obstet. Gynecol. Reprod. Biol. 61 (1995) 151-155
14. Tornell, J., C. Bergh, U. Selleskog, T. Hillensjö: Effet of recombinant human gonadotropins on oocyte meiosis and steroidogenesis in isolated preovulating rat follicles. Hum. Reprod. 10 (1995) 1619-1622
15. Strowitzki, T., H. Kentenich, L. Kiesel, J. Neulen, W. Bilger: Ovarian stimulation in woman undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulation hormone (Gonal-F) in non-downregulated cycles. Hum. Reprod. 10 (1995) 3097-3101
16. Staessen, C., M. Camus, I. Khan, J. Smitz, L. Van Waesberge, A. Wisanto, P. Devroey, A. C. Van Steirteghem: An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen thawed embryos. J. Vito. Fertil. Embryo Transfer 6 (1989) 22-29
17. Keller, R., H. L. Günther, P. Kaiser: Embryonenschutzgesetz. Kommentar zum Embryonenschutzgesetz. Kohlhammer, Stuttgart (1992)
18. Devroey, P., B. Maennerts, J. Smitz et al.: Clinical outcome of a pilot efficacy study in recombinant human FSH (Org 32489) combined with various GnRH agonist regimens. Hum. Reprod. 9 (1994) 788-791
19. Albano, C., J. Smitz, M. Camus et al.: Comparison of different doses of gonadotropin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation. Fertil. Steril. 67 (1997) 917-922
20. DIR Deutches IVF-Register (1996)
21. Felberbaum, R., T. Reissmann, W. Kupker et al.: Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages. J. Assist. Reprod. Genet. 13 (3) (1996) 216-222